MBOT

SEC filing MBOT Secures First North Carolina Customer, Expands LIBERTY ® System Adoption Across Southeast, Mid-Atlantic and Northeast U.S. Markets

5h ago

SEC filing MBOT Receives Israeli Regulatory Approval for LIBERTY Endovascular Robotic System, Enables Free Sale Certificate for Global Expansion

7d ago

News Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY - Zacks Investment Research

14d ago

News Microbot Medical plunges amid results, short report from White Diamond Research

19d ago

SEC filing MBOT Reports Q1 Revenue from Limited Release, Q2 Revenue Already Exceeds Q1, Accounts Double, Full Market Release Launched

19d ago

SEC filing MBOT Reports Strong Physician Interest in LIBERTY Endovascular Robotic System Following SIR Launch

28d ago

SEC filing MBOT Announces LIBERTY® Endovascular Robotic System Full Market Release at Needham Conference, CEO to Present Live

49d ago

SEC filing MBOT Announces Full Market Release of LIBERTY Endovascular Robotic System at SIR Conference with Adoption by Emory Healthcare and Tampa General Hospital

50d ago

SEC filing MBOT ATM Offering Up to $39.2M Common Stock via H.C. Wainwright, Prospectus Supplement Filed

52d ago

SEC filing MBOT Announces In Vivo Study Results in JVIR, Launches $15M IPO, +120% Revenue Growth

70d ago

SEC filing MBOT Confirms Operational Stability Amid Geopolitical Tensions in Middle East

91d ago

News Year Two Of The Largest Ever Global LNG Supply Wave Is Hitting Markets

115d ago

Short volume Short volume 64% of volume (3.1σ)

118d ago

News Bridge Tower Homes and Hankyu Hanshin Properties Announce Strategic Joint Venture to Launch Residential For-Sale Partnership Across Texas – Company Announcement

126d ago

News Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

153d ago